Cargando…
FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis
B cells are critical to the development of multiple sclerosis (MS), but the mechanisms by which they contribute to the disease are poorly defined. We hypothesised that the expression of CD32b (FcγRIIb), a receptor for the Fc region of IgG with inhibitory activities in B cells, is lower on B cell sub...
Autores principales: | Trend, Stephanie, Leffler, Jonatan, Teige, Ingrid, Frendéus, Björn, Kermode, Allan G., French, Martyn A., Hart, Prue H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832177/ https://www.ncbi.nlm.nih.gov/pubmed/33505402 http://dx.doi.org/10.3389/fimmu.2020.614492 |
Ejemplares similares
-
Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy–Focus on FcγRIIB
por: Teige, Ingrid, et al.
Publicado: (2019) -
FcγRIIB regulates autoantibody responses by limiting marginal zone B cell activation
por: Barlev, Ashley N., et al.
Publicado: (2022) -
FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms
por: Simpson, Alexander P., et al.
Publicado: (2022) -
Narrowband UVB phototherapy reduces TNF production by B‐cell subsets stimulated via TLR7 from individuals with early multiple sclerosis
por: Trend, Stephanie, et al.
Publicado: (2020) -
Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma
por: Jiang, Vivian Changying, et al.
Publicado: (2022)